FDA approval
-
Lilly’s Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer’s Disease
Congratulations to Eli Lilly and AD patients!
-
Sarepta Therapeutics Announces Expanded US FDA Approval of ELEVIDYS to Duchenne Muscular Dystrophy Patients Ages 4 and Above
Congratulations to Sarepta Therapeutics and DMD patients!
